Literature DB >> 27871021

Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosis.

Danielle Colledge1, Sally Soppe1, Lilly Yuen1, Lucy Selleck1, Renae Walsh1, Stephen Locarnini2, Nadia Warner1.   

Abstract

Premature stop codons in the hepatitis B virus (HBV) surface protein can be associated with nucleos(t)ide analogue resistance due to overlap of the HBV surface and polymerase genes. The aim of this study was to determine the effect of the replication of three common surface stop codon variants on the hepatocyte. Cell lines were transfected with infectious HBV clones encoding surface stop codons rtM204I/sW196*, rtA181T/sW172*, rtV191I/sW182*, and a panel of substitutions in the surface proteins. HBsAg was measured by Western blotting. Proliferation and apoptosis were measured using flow cytometry. All three surface stop codon variants were defective in HBsAg secretion. Cells transfected with these variants were less proliferative and had higher levels of apoptosis than those transfected with variants that did not encode surface stop codons. The most cytopathic variant was rtM204I/sW196*. Replication of HBV encoding surface stop codons was toxic to the cell and promoted apoptosis, exacerbating disease progression.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cytopathic variant; Hepatitis B virus; Nucleos(t)ide analogue resistance; Pathogenic variants; Surface stop codons

Mesh:

Substances:

Year:  2016        PMID: 27871021     DOI: 10.1016/j.virol.2016.11.007

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

1.  Complementation of Wild-Type and Drug-Resistant Hepatitis B Virus Genomes to Maintain Viral Replication and Rescue Virion Production under Nucleos(t)ide Analogs.

Authors:  Chunchen Wu; Baolin Li; Xiaoyong Zhang; Kaitao Zhao; Yingshan Chen; Yifei Yuan; Yan Liu; Rongjuan Chen; Dongping Xu; Xinwen Chen; Mengji Lu
Journal:  Virol Sin       Date:  2019-06-19       Impact factor: 4.327

2.  Hepatitis B Virus preS/S Truncation Mutant rtM204I/sW196* Increases Carcinogenesis through Deregulated HIF1A, MGST2, and TGFbi.

Authors:  Ming-Wei Lai; Kung-Hao Liang; Chau-Ting Yeh
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

Review 3.  Prophylaxis of Hepatitis B Virus (HBV) Re-Infection in Liver Transplantation: Is the Reappearance of Hepatitis B Surface Antigen (HBsAg) Significant?

Authors:  Giuseppina Brancaccio; Giovanni B Gaeta
Journal:  Ann Transplant       Date:  2020-03-31       Impact factor: 1.530

4.  Efficient silencing of hepatitis B virus S gene through CRISPR-mediated base editing.

Authors:  Hao Zhou; Xiaomei Wang; Clifford J Steer; Guisheng Song; Junqi Niu
Journal:  Hepatol Commun       Date:  2022-03-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.